Delayed allograft rejection by the suppression of class II transactivator

Citations Over Time

Abstract

(CIITA) down-modulation on allograft rejection. To inhibit the function of CIITA, we constructed a series of CIITA mutants and found one exhibiting the dominant-negative effect on the regulation of major histocompatibility complex (MHC) class II expression. To test whether the CIITA dominant-negative mutant reduces immunogenicity, CIITA-transfected melanoma cells were injected into allogeneic host and assessed for immune evading activity against host immune cells. We demonstrated that the CIITA dominant-negative mutant allowed tumor nodules to develop earlier in the lung than control by this tumor challenge study. Furthermore, skin grafts deficient for CIITA also survived longer than wild-type in allogeneic hosts. Both the tumor challenge and skin graft studies suggest the inhibition of CIITA molecules in donor tissue would be beneficial to the control of allo-response.

Related Papers

• → Mice Lacking the MHC Class II Transactivator (CIITA) Show Tissue-Specific Impairment of MHC Class II Expression(1996)353 cited
• → The RFX Complex Is Crucial for the Constitutive and CIITA-Mediated Transactivation of MHC Class I and β2-Microglobulin Genes(1998)114 cited
• → CpG DNA Induces a Class II Transactivator-Independent Increase in Class II MHC by Stabilizing Class II MHC mRNA in B Lymphocytes(2003)19 cited
• → Tu1870 IL-27 Activates MHC Class II Expression in Intestinal Epithelial Cells via STAT1-Dependent Class II Transactivator (CIITA) Induction(2012)
• → IL-27 activates MHC class II expression in intestinal epithelial cells via STAT1-dependent class II transactivator (CIITA) induction(2012)